551 related articles for article (PubMed ID: 11795527)
21. Advanced glycation endproducts in food and their effects on health.
Poulsen MW; Hedegaard RV; Andersen JM; de Courten B; Bügel S; Nielsen J; Skibsted LH; Dragsted LO
Food Chem Toxicol; 2013 Oct; 60():10-37. PubMed ID: 23867544
[TBL] [Abstract][Full Text] [Related]
22. Towards the control and inhibition of glycation-the role of the guanidine reaction center with aldehydic and diketonic dicarbonyls. A mass spectrometry study.
Saraiva MA; Borges CM; Florêncio MH
J Mass Spectrom; 2006 Oct; 41(10):1346-68. PubMed ID: 17039581
[TBL] [Abstract][Full Text] [Related]
23. Native protein glycoxidation and aging.
Meli M; Frey J; Perier C
J Nutr Health Aging; 2003; 7(4):263-6. PubMed ID: 12917752
[TBL] [Abstract][Full Text] [Related]
24. Myoglobin-induced oxidative damage: evidence for radical transfer from oxidized myoglobin to other proteins and antioxidants.
Irwin JA; Ostdal H; Davies MJ
Arch Biochem Biophys; 1999 Feb; 362(1):94-104. PubMed ID: 9917333
[TBL] [Abstract][Full Text] [Related]
25. Maillard reactions by alpha-oxoaldehydes: detection of glyoxal-modified proteins.
Sady C; Jiang CL; Chellan P; Madhun Z; Duve Y; Glomb MA; Nagaraj RH
Biochim Biophys Acta; 2000 Sep; 1481(2):255-64. PubMed ID: 11018716
[TBL] [Abstract][Full Text] [Related]
26. Immunological evidence that non-carboxymethyllysine advanced glycation end-products are produced from short chain sugars and dicarbonyl compounds in vivo.
Takeuchi M; Makita Z; Bucala R; Suzuki T; Koike T; Kameda Y
Mol Med; 2000 Feb; 6(2):114-25. PubMed ID: 10859028
[TBL] [Abstract][Full Text] [Related]
27. Advanced glycation endproducts and cigarette smoking.
Nicholl ID; Bucala R
Cell Mol Biol (Noisy-le-grand); 1998 Nov; 44(7):1025-33. PubMed ID: 9846884
[TBL] [Abstract][Full Text] [Related]
28. Peptide and amino acid glycation: new insights into the Maillard reaction.
Horvat S; Jakas A
J Pept Sci; 2004 Mar; 10(3):119-37. PubMed ID: 15113085
[TBL] [Abstract][Full Text] [Related]
29. Formation of crossline as a fluorescent advanced glycation end product in vitro and in vivo.
Obayashi H; Nakano K; Shigeta H; Yamaguchi M; Yoshimori K; Fukui M; Fujii M; Kitagawa Y; Nakamura N; Nakamura K; Nakazawa Y; Ienaga K; Ohta M; Nishimura M; Fukui I; Kondo M
Biochem Biophys Res Commun; 1996 Sep; 226(1):37-41. PubMed ID: 8806589
[TBL] [Abstract][Full Text] [Related]
30. The other side of the Maillard reaction.
Nagaraj RH; Biswas A; Miller A; Oya-Ito T; Bhat M
Ann N Y Acad Sci; 2008 Apr; 1126():107-12. PubMed ID: 18448802
[TBL] [Abstract][Full Text] [Related]
31. DNA damage during glycation of lysine by methylglyoxal: assessment of vitamins in preventing damage.
Suji G; Sivakami S
Amino Acids; 2007 Nov; 33(4):615-21. PubMed ID: 18004515
[TBL] [Abstract][Full Text] [Related]
32. Effect of buformin and metformin on formation of advanced glycation end products by methylglyoxal.
Kiho T; Kato M; Usui S; Hirano K
Clin Chim Acta; 2005 Aug; 358(1-2):139-45. PubMed ID: 15946656
[TBL] [Abstract][Full Text] [Related]
33. Experimental studies on the role of fructose in the development of diabetic complications.
Sakai M; Oimomi M; Kasuga M
Kobe J Med Sci; 2002 Dec; 48(5-6):125-36. PubMed ID: 12594356
[TBL] [Abstract][Full Text] [Related]
34. Methylglyoxal: its presence in beverages and potential scavengers.
Tan D; Wang Y; Lo CY; Sang S; Ho CT
Ann N Y Acad Sci; 2008 Apr; 1126():72-5. PubMed ID: 18448797
[TBL] [Abstract][Full Text] [Related]
35. Advanced glycation endproducts (AGEs): Pharmacological inhibition in diabetes.
Peyroux J; Sternberg M
Pathol Biol (Paris); 2006 Sep; 54(7):405-19. PubMed ID: 16978799
[TBL] [Abstract][Full Text] [Related]
36. Inhibitors of the Maillard reaction and AGE breakers as therapeutics for multiple diseases.
Reddy VP; Beyaz A
Drug Discov Today; 2006 Jul; 11(13-14):646-54. PubMed ID: 16793534
[TBL] [Abstract][Full Text] [Related]
37. Processing of protein glycation, oxidation and nitrosation adducts in the liver and the effect of cirrhosis.
Ahmed N; Thornalley PJ; Lüthen R; Häussinger D; Sebekova K; Schinzel R; Voelker W; Heidland A
J Hepatol; 2004 Dec; 41(6):913-9. PubMed ID: 15582123
[TBL] [Abstract][Full Text] [Related]
38. Fructose-mediated non-enzymatic glycation: sweet coupling or bad modification.
Schalkwijk CG; Stehouwer CD; van Hinsbergh VW
Diabetes Metab Res Rev; 2004; 20(5):369-82. PubMed ID: 15343583
[TBL] [Abstract][Full Text] [Related]
39. Cyperus rotundus suppresses AGE formation and protein oxidation in a model of fructose-mediated protein glycoxidation.
Ardestani A; Yazdanparast R
Int J Biol Macromol; 2007 Dec; 41(5):572-8. PubMed ID: 17765965
[TBL] [Abstract][Full Text] [Related]
40. Acid-stable fluorescent advanced glycation end products: vesperlysines A, B, and C are formed as crosslinked products in the Maillard reaction between lysine or proteins with glucose.
Nakamura K; Nakazawa Y; Ienaga K
Biochem Biophys Res Commun; 1997 Mar; 232(1):227-30. PubMed ID: 9125137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
